Effects of acute administration of a single dose of Cannabis Extract on laboratory-induced pain: comparison with placebo

Phase 4

• Conditions: Pain Perception; Pain Measurement; Pain Threshold; C23.888.592.612.081

• Registration Number: RBR-5ghx4y6
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo FMRP - USP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-10-26
• Last Update Posted: 13 November 2023
• Study Completion: 2025-11-29

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Participants aged at least 18 years; both genders; absence of current or previous history (self-reported) of substance abuse, psychiatric disorders and/or neurological disorders, cardiovascular diseases, pulmonary diseases, high blood pressure; absence of painful disorders and complaints of chronic or acute pain; score less than ten on the Patient Health Questionnaire (PHQ-9), on the Generalized Anxiety Instrument (GAD-7); absence of experience of pain of any kind in the seven days prior to the experimental session, assessed by means of a checklist questionnaire of pre-existing painful conditions and the perception of present pain (Visual Analog Pain Scale)

Exclusion Criteria

Adverse reactions of any nature after the use of cannabis extract; failure to complete the experimental tasks that make up the study

Study & Design

• Study Type: Intervention
• Study Design: Not specified